Uji klinis HIV di Georgia
14 studi untuk HIV mencari peserta di lokasi di Georgia.
Kota di Georgia
Teks studi resmi (Bahasa Inggris)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Faebris Medical & Community Education, Atlanta
- Grady Memorial Hospital, Atlanta
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Decatur
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Metro Infectious Diseases Consultants L.L.C. ( Site 1509), Decatur
- Mercer university, Department of internal medicine-Clinical Research ( Site 1512), Macon
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07266831Screen2Prevent (S2P)
- Emory Atlanta Adolescent Consortium, Atlanta
Menerima pesertaSukarelawan sehat diterima
Usia 14 hingga 24 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Atlanta ID Group, PC, Atlanta
- Chatham County Health Department, Savannah
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07682961A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Atlanta
- GSK Investigational Site, Macon
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07202546Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Emory Children's Center ( Site 0103), Atlanta
Menerima pesertaFase 2
4 Weeks – 11 Years · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT04375800Inflammation and Depression in People With HIV
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Mei 2026 · NCT05849038Menopausal HT for Women Living With HIV (HoT)
- The Ponce de Leon Center CRS (5802), Atlanta
Menerima pesertaFase 4
Usia 40 hingga 60 · Wanita · Diperbarui 22 Mei 2026 · NCT06856174Low Dose Naltrexone for Pain in Patients With HIV
- Grady Memorial Hospital, Atlanta
- Emory Midtown Hospital, Atlanta
- Emory University Hospital, Atlanta
Menerima pesertaFase 4
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT05537935Baricitinib for Reduction of HIV - CNS
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT05452564Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
- Ponce de Leon Center CRS, Atlanta
- The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 25 Sep 2025 · NCT06796686HIV Treatment Adherence Dose Determination Trial
- University of Connecticut Field Site, Atlanta
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Agu 2025 · NCT04577313Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Atlanta
Menerima pesertaFase 1/2
Usia 6 hingga 12 · Semua jenis kelamin · Diperbarui 19 Sep 2024 · NCT05674656Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.